ATC
KNSA icon

Adirondack Trust Company’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Adirondack Trust Company’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-875
Closed -$16.3K – 498
2024
Q2 		$16.3K Hold
875
– – 0.01% 320
2024
Q1 		$17.3K Hold
875
– – 0.01% 315
2023
Q4 		$18.5K Hold
875
– – 0.01% 308
2023
Q3 		$15.2K Hold
875
– – 0.01% 309
2023
Q2 		$16.5K Hold
875
– – 0.01% 285
2023
Q1 		$9.41K Hold
875
– – ﹤0.01% 338
2022
Q4 		$13.1K Hold
875
– – 0.01% 301
2022
Q3 		$11K Hold
875
– – 0.01% 310
2022
Q2 		$8K Hold
875
– – ﹤0.01% 336
2022
Q1 		$9K Buy
875
+445
+103% +$4.71K ﹤0.01% 327
2021
Q4 		$5K Buy
+430
New +$5.28K ﹤0.01% 356

Other funds holding KNSA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

Adirondack Trust Company's KNSA Position: Q3 2024 in Review

Adirondack Trust Company sold out of Kiniksa Pharmaceuticals (KNSA) in Q3 2024, closing a stake of 875 shares — an estimated $16.3K sold.

Adirondack Trust Company first reported a position in KNSA in Q4 2021 and held it in 11 quarters. The position peaked at $18.5K in Q4 2023. 176 funds tracked by Wall St. Rank hold KNSA as of Q3 2024.

  • Adirondack Trust Company reported no remaining Kiniksa Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Adirondack Trust Company sold 875 Kiniksa Pharmaceuticals shares in Q3 2024, an estimated $16.3K.
  • Adirondack Trust Company first reported a position in Kiniksa Pharmaceuticals in Q4 2021 and held it in 11 quarters.
  • Adirondack Trust Company's Kiniksa Pharmaceuticals position peaked at $18.5K in Q4 2023.
  • 176 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q3 2024.

Based on Adirondack Trust Company's 13F filing for Q3 2024, filed 8 Oct 2024.